Vaccination in post-tuberculosis lung disease management : A review of the evidence
Copyright © 2023 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved..
INTRODUCTION AND OBJECTIVES: Post-tuberculosis lung disease (PTLD), as other chronic respiratory disorders, may have infectious complications; some of them can be prevented with vaccinations. So far, no document has discussed the potential role of vaccination in PTLD. Therefore, the objective of this review was to describe vaccination recommendations to prevent infections potentially capable of complicating PTLD.
MATERIALS AND METHODS: A non-systematic review of the literature was conducted. The following keywords were used: tuberculosis, vaccination, vaccines and PTLD. PubMed/MEDLINE and Embase were used as the search engine, focusing on English-language literature only.
RESULTS: We identified 9 vaccines potentially useful in PTLD. Influenza, pneumococcal and anti-COVID-19 vaccinations should be recommended. Patients with PTLD can also benefit from vaccination against shingles. Vaccination against pertussis is mainly relevant during childhood. Diphtheria, tetanus and measles vaccination are recommended for general population and should be considered in patients with PTLD not previously vaccinated. Tdap (Tetanus, diphtheria, and pertussis) booster should be repeated in every adult every ten years. Vaccination against BCG retains its importance during early childhood in countries where TB is endemic.
CONCLUSIONS: Vaccination deserves to be considered among the strategies to prevent and/or mitigate PTLD complications. Further evidence is necessary to better understand which vaccines have the greatest impact and cost-benefit.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
Pulmonology - (2023) vom: 05. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Nasiri, M J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Revised 14.12.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.pulmoe.2023.07.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361768214 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361768214 | ||
| 003 | DE-627 | ||
| 005 | 20231227131543.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pulmoe.2023.07.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM361768214 | ||
| 035 | |a (NLM)37679219 | ||
| 035 | |a (PII)S2531-0437(23)00129-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nasiri, M J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vaccination in post-tuberculosis lung disease management |b A review of the evidence |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2023 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a INTRODUCTION AND OBJECTIVES: Post-tuberculosis lung disease (PTLD), as other chronic respiratory disorders, may have infectious complications; some of them can be prevented with vaccinations. So far, no document has discussed the potential role of vaccination in PTLD. Therefore, the objective of this review was to describe vaccination recommendations to prevent infections potentially capable of complicating PTLD | ||
| 520 | |a MATERIALS AND METHODS: A non-systematic review of the literature was conducted. The following keywords were used: tuberculosis, vaccination, vaccines and PTLD. PubMed/MEDLINE and Embase were used as the search engine, focusing on English-language literature only | ||
| 520 | |a RESULTS: We identified 9 vaccines potentially useful in PTLD. Influenza, pneumococcal and anti-COVID-19 vaccinations should be recommended. Patients with PTLD can also benefit from vaccination against shingles. Vaccination against pertussis is mainly relevant during childhood. Diphtheria, tetanus and measles vaccination are recommended for general population and should be considered in patients with PTLD not previously vaccinated. Tdap (Tetanus, diphtheria, and pertussis) booster should be repeated in every adult every ten years. Vaccination against BCG retains its importance during early childhood in countries where TB is endemic | ||
| 520 | |a CONCLUSIONS: Vaccination deserves to be considered among the strategies to prevent and/or mitigate PTLD complications. Further evidence is necessary to better understand which vaccines have the greatest impact and cost-benefit | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Mycobacterium tuberculosis | |
| 650 | 4 | |a Post-tuberculosis lung disease | |
| 650 | 4 | |a Respiratory infections | |
| 650 | 4 | |a Vaccination | |
| 700 | 1 | |a Silva, D R |e verfasserin |4 aut | |
| 700 | 1 | |a Rommasi, F |e verfasserin |4 aut | |
| 700 | 1 | |a Zahmatkesh, M M |e verfasserin |4 aut | |
| 700 | 1 | |a Tajabadi, Z |e verfasserin |4 aut | |
| 700 | 1 | |a Khelghati, F |e verfasserin |4 aut | |
| 700 | 1 | |a Sarmastzadeh, T |e verfasserin |4 aut | |
| 700 | 1 | |a Centis, R |e verfasserin |4 aut | |
| 700 | 1 | |a D'Ambrosio, L |e verfasserin |4 aut | |
| 700 | 1 | |a Bombarda, S |e verfasserin |4 aut | |
| 700 | 1 | |a Dalcolmo, M P |e verfasserin |4 aut | |
| 700 | 1 | |a Galvão, T |e verfasserin |4 aut | |
| 700 | 1 | |a de Queiroz Mello, F C |e verfasserin |4 aut | |
| 700 | 1 | |a Rabahi, M F |e verfasserin |4 aut | |
| 700 | 1 | |a Pontali, E |e verfasserin |4 aut | |
| 700 | 1 | |a Solovic, I |e verfasserin |4 aut | |
| 700 | 1 | |a Tadolini, M |e verfasserin |4 aut | |
| 700 | 1 | |a Marconi, L |e verfasserin |4 aut | |
| 700 | 1 | |a Tiberi, S |e verfasserin |4 aut | |
| 700 | 1 | |a van den Boom, M |e verfasserin |4 aut | |
| 700 | 1 | |a Sotgiu, G |e verfasserin |4 aut | |
| 700 | 1 | |a Migliori, G B |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pulmonology |d 2017 |g (2023) vom: 05. Sept. |w (DE-627)NLM278404561 |x 2531-0437 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:05 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pulmoe.2023.07.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 05 |c 09 | ||